Literature DB >> 31509318

Experimental models for cutaneous hypertrophic scar research.

Jialun Li1, Jiecong Wang1, Zhenxing Wang1, Yun Xia1, Muran Zhou1, Aimei Zhong1, Jiaming Sun1.   

Abstract

Human skin wound repair may result in various outcomes with most of them leading to scar formation. Commonly seen in many cutaneous wound healing cases, hypertrophic scars are considered as phenotypes of abnormal wound repair. To prevent the formation of hypertrophic scars, efforts have been made to understand the mechanism of scarring following wound closure. Numerous in vivo and in vitro models have been created to facilitate investigations into cutaneous scarring and the development of antiscarring treatments. To select the best model for a specific study, background knowledge of the current models of hypertrophic scars is necessary. In this review, we describe in vivo and in vitro models for studying hypertrophic scars, as well as the distinct characteristics of these models. The choice of models for a specific study should be based on the characteristics of the model and the goal of the study. In general, in vivo animal models are often used in phenotypical scar formation analysis, development of antiscarring treatment, and functional analyses of individual genes. In contrast, in vitro models are chosen to pathway identification during scar formation as well as in high-throughput analysis in drug development. Besides helping investigators choose the best scarring model for their research, the goal of this review is to provide knowledge for improving the existing models and development of new models. These will contribute to the progress of scarring studies.
© 2019 by the Wound Healing Society.

Entities:  

Mesh:

Year:  2019        PMID: 31509318     DOI: 10.1111/wrr.12760

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  8 in total

1.  A Rodent Model of Hypertrophic Scarring: Splinting of Rat Wounds.

Authors:  Dong Ok Son; Boris Hinz
Journal:  Methods Mol Biol       Date:  2021

2.  Advancements in the Delivery of Growth Factors and Cytokines for the Treatment of Cutaneous Wound Indications.

Authors:  Caitlin Berry-Kilgour; Jaydee Cabral; Lyn Wise
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-11-25       Impact factor: 4.730

3.  Lycorine Inhibits Hypertrophic Scar Formation by Inducing ROS-Mediated Apoptosis.

Authors:  Yunxian Dong; Dongming Lv; Zirui Zhao; Zhongye Xu; Zhicheng Hu; Bing Tang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-24

4.  miR-205 inhibits the development of hypertrophic scars by targeting THBS1.

Authors:  Dongwen Jiang; Bingyu Guo; Feng Lin; Shixiu Lin; Kai Tao
Journal:  Aging (Albany NY)       Date:  2020-11-13       Impact factor: 5.682

5.  Modeling of Old Scars: Histopathological, Biochemical and Thermal Analysis of the Scar Tissue Maturation.

Authors:  Alexey Fayzullin; Natalia Ignatieva; Olga Zakharkina; Mark Tokarev; Daniil Mudryak; Yana Khristidis; Maxim Balyasin; Alexandr Kurkov; Semyon Churbanov; Tatyana Dyuzheva; Peter Timashev; Anna Guller; Anatoly Shekhter
Journal:  Biology (Basel)       Date:  2021-02-09

6.  Skin Grafting Using Collagen Fiber Orientation Matching.

Authors:  Masamitsu Kuwahara; Shigeyoshi Osaki; Hideo Asada
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-01-24

7.  Histological Analysis of the Effect of Nanofat Grafting in Scar Rejuvenation.

Authors:  Dasari Madhu VinayKumar; Subair Mohsina; Satyaswarup Tripathy; Ramesh Kumar Sharma; Alka Bhatia
Journal:  J Cutan Aesthet Surg       Date:  2022 Apr-Jun

8.  Uvaol Improves the Functioning of Fibroblasts and Endothelial Cells and Accelerates the Healing of Cutaneous Wounds in Mice.

Authors:  Julianderson Carmo; Polliane Cavalcante-Araújo; Juliane Silva; Jamylle Ferro; Ana Carolina Correia; Vincent Lagente; Emiliano Barreto
Journal:  Molecules       Date:  2020-10-28       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.